[go: up one dir, main page]

MX2014000753A - Procedimiento para producir antigeno viral y vacunas. - Google Patents

Procedimiento para producir antigeno viral y vacunas.

Info

Publication number
MX2014000753A
MX2014000753A MX2014000753A MX2014000753A MX2014000753A MX 2014000753 A MX2014000753 A MX 2014000753A MX 2014000753 A MX2014000753 A MX 2014000753A MX 2014000753 A MX2014000753 A MX 2014000753A MX 2014000753 A MX2014000753 A MX 2014000753A
Authority
MX
Mexico
Prior art keywords
viral antigen
enveloped virus
vaccines
producing viral
fluid
Prior art date
Application number
MX2014000753A
Other languages
English (en)
Inventor
Yi-Qing Cui
Yiding Wang
Jo Thus
Hof Ron Van T
Sabah Shaker
Geertje Jacoba Van Rooij
Original Assignee
Abbott Biologicals Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Biologicals Bv filed Critical Abbott Biologicals Bv
Publication of MX2014000753A publication Critical patent/MX2014000753A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/36—Extraction; Separation; Purification by a combination of two or more processes of different types
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C12N7/02—Recovery or purification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16151—Methods of production or purification of viral material

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

La presente invención pertenece al campo de la industria farmacéutica y se relaciona con un método para la producción de antígeno viral derivado de virus encapsulado, que comprende los pasos de proporcionar un fluido que comprende virus encapsulado, clarificar el fluido que comprende dicho virus encapsulado, reducir el volumen de la cosecha líquida obtenida, solubilizar el virus encapsulado y purificar el antígeno viral; la presente invención además se refiere al uso de dicho método para la producción de una preparación de vacuna.
MX2014000753A 2011-07-20 2012-07-04 Procedimiento para producir antigeno viral y vacunas. MX2014000753A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161509630P 2011-07-20 2011-07-20
EP11174660 2011-07-20
PCT/EP2012/063045 WO2013010797A1 (en) 2011-07-20 2012-07-04 Process for producing viral antigen and vaccines

Publications (1)

Publication Number Publication Date
MX2014000753A true MX2014000753A (es) 2014-05-07

Family

ID=45094875

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2014000753A MX2014000753A (es) 2011-07-20 2012-07-04 Procedimiento para producir antigeno viral y vacunas.

Country Status (12)

Country Link
EP (1) EP2734619B1 (es)
JP (1) JP6275641B2 (es)
KR (2) KR20140038530A (es)
CN (1) CN103827296B (es)
AU (1) AU2012286098C1 (es)
BR (1) BR112014001049A2 (es)
CA (1) CA2841604C (es)
ES (1) ES2653197T3 (es)
MX (1) MX2014000753A (es)
RU (1) RU2565827C2 (es)
TW (1) TW201311896A (es)
WO (1) WO2013010797A1 (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109568573A (zh) * 2014-12-12 2019-04-05 普莱柯生物工程股份有限公司 疫苗组合物及其制备方法和应用
CN111511756B (zh) 2017-12-19 2023-11-03 康诺贝林伦瑙有限公司 使用烷基糖苷类进行蛋白质纯化和病毒灭活
JP7360594B2 (ja) * 2017-12-28 2023-10-13 共立製薬株式会社 ワクチン製剤、並びに魚類のイリドウイルス感染症予防方法
US11690907B2 (en) 2018-06-12 2023-07-04 Kbio Holdings Limited Vaccines formed by virus and antigen conjugation
US11696948B2 (en) 2018-06-12 2023-07-11 Kbio Holdings Limited Vaccines formed by virus and antigen conjugation
US11529413B2 (en) 2018-06-12 2022-12-20 Kbio Holdings Limited Virus and antigen purification and conjugation
US10822591B2 (en) 2018-06-12 2020-11-03 Kentucky Bioprocessing, Inc. Virus purification
EP3818150A1 (en) * 2018-07-04 2021-05-12 ProBioGen AG Method for purifying an enveloped virus
MX2021005685A (es) 2018-11-15 2021-07-07 Bayer Healthcare Llc Metodos de inactivacion virica para la fabricacion continua de anticuerpos.
RU2710239C1 (ru) * 2019-06-14 2019-12-25 Федеральное государственное унитарное предприятие "Санкт-Петербургский научно-исследовательский институт вакцин и сывороток и предприятие по производству бактерийных препаратов" Федерального медико-биологического агентства Способ получения антигена или антигенов для производства противогриппозной вакцины и вакцина на его основе
BR112022008711A2 (pt) * 2019-11-07 2022-07-19 Seqirus Uk Ltd Métodos para produzir uma vacina viral e reduzir o tamanho da partícula viral
US20230212230A1 (en) * 2020-04-29 2023-07-06 Sk Bioscience Co., Ltd. Influenza virus production method using single-use culture process system and rapid confirmation test of influenza virus antigen purification condition
KR102546626B1 (ko) * 2020-04-29 2023-06-21 에스케이바이오사이언스(주) 인플루엔자 바이러스 항원 정제 조건 신속 확인 시험
CN112309502B (zh) * 2020-10-14 2024-09-20 深圳市新合生物医疗科技有限公司 一种计算肿瘤新抗原负荷的方法及系统
JP2023141423A (ja) * 2022-03-24 2023-10-05 国立大学法人 東京大学 ウイルスの精製方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4140762A (en) * 1974-01-14 1979-02-20 Sandoz Ltd. Influenza sub-unit vaccine
US4240762A (en) * 1979-03-12 1980-12-23 Johnston Pump Company Seal-aligning rigid coupling assembly
SE8405493D0 (sv) * 1984-11-01 1984-11-01 Bror Morein Immunogent komplex samt sett for framstellning derav och anvendning derav som immunstimulerande medel
WO2005014862A1 (en) * 2003-02-25 2005-02-17 Medimmune Vaccines, Inc. Methods of producing inflenza vaccine compositions
RU2283139C1 (ru) * 2005-03-21 2006-09-10 Федеральное государственное унитарное предприятие "Научно-производственное объединение по медицинским иммунобиологическим препаратам "Микроген" Министерства здравоохранения Российской Федерации Способ получения антигенов для вакцины против вирусов гриппа
EP1982727A1 (en) * 2007-04-17 2008-10-22 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Method for purification of viral proteins
US8497112B2 (en) * 2007-08-28 2013-07-30 Baxter International Inc. Method for producing viral vaccines
EP2889042A3 (en) * 2008-03-18 2015-10-14 Novartis AG Improvements in preparation of influenza virus vaccine antigens
CN102216450B (zh) * 2008-09-24 2014-05-14 米迪缪尼有限公司 培养细胞、增殖和纯化病毒的方法
WO2010036774A1 (en) * 2008-09-24 2010-04-01 Medimmune, Llc Methods for purification of viruses
GB0918830D0 (en) * 2009-10-27 2009-12-09 Glaxosmithkline Biolog Niederl Process

Also Published As

Publication number Publication date
JP6275641B2 (ja) 2018-02-07
AU2012286098A1 (en) 2014-01-23
CA2841604A1 (en) 2013-01-24
AU2012286098C1 (en) 2016-09-15
WO2013010797A1 (en) 2013-01-24
JP2014524747A (ja) 2014-09-25
CN103827296A (zh) 2014-05-28
KR20160096215A (ko) 2016-08-12
RU2014101484A (ru) 2015-07-27
TW201311896A (zh) 2013-03-16
CA2841604C (en) 2020-01-21
EP2734619B1 (en) 2017-09-06
ES2653197T3 (es) 2018-02-06
RU2565827C2 (ru) 2015-10-20
BR112014001049A2 (pt) 2017-02-21
CN103827296B (zh) 2016-11-16
KR20140038530A (ko) 2014-03-28
EP2734619A1 (en) 2014-05-28

Similar Documents

Publication Publication Date Title
MX2014000753A (es) Procedimiento para producir antigeno viral y vacunas.
PH12018500916A1 (en) Antibody neutralizing human respiratory syncytial virus
MX394097B (es) Producción de partículas similares a virus en plantas.
MX352338B (es) Anticuerpos neutralizantes del virus de la influenza a y usos de estos.
MX2010003202A (es) Metodo para producir virus de la gripe.
MY161965A (en) New influenza virus immunizing epitope
MX2015009613A (es) Proceso para preparar un producto lacteo fermentado colado.
EA201490583A1 (ru) Удаление примесных вирусов из препаратов аав
MX354750B (es) PARTÍCULAS PSEUDO-VIRALES (PPVs) QUE COMPRENDEN GLICOPROTEÍNAS DEL VIRUS DE LA RABIA.
WO2010148511A8 (en) Chimeric influenza virus-like particles comprising hemagglutinin
FR2967072B1 (fr) Procede pour ameliorer la production de virus et semences vaccinales influenza
EA033455B1 (ru) Кристаллические формы замещенных 5-фтор-1h-пиразолопиридинов, способы их получения, их применение для получения лекарственного средства, лекарственное средство и способ лечения на их основе
MX376138B (es) Produccion de particulas similares a virus de influenza en plantas.
PH12014500640A1 (en) Increasing virus-like particle yield in plants
EP2873423A3 (en) Soluble hiv-1 envelope glycoprotein trimers
MX2013013228A (es) Particulas similares a virus y proceso para prepararlas.
EA201400216A1 (ru) Консервирование биологических продуктов, в частности вакцин, с применением вакуума
GEP20227351B (en) Preparation of solid dosage forms comprising antibodies by solution/suspension layering
WO2013055326A3 (en) Vaccines for human papilloma virus and methods for using the same
EA201592298A1 (ru) Полуживая вирусная вакцина против респираторно-синцитиального вируса
FR2998579B1 (fr) Methode pour obtenir des anticorps humains specifiques d'un antigene par immunisation in vitro
MY183980A (en) Commercial scale process for production of prrsv
EP2484757A4 (en) VIRUS FOR THE EXPRESSION OF ALPHA GALACTOSE EPITOPES AND METHOD FOR THE PRODUCTION OF A VACCINE
IN2015DN02772A (es)
PH12013501794A1 (en) Preparation method of new recombinant antibacterial polypeptide medicine

Legal Events

Date Code Title Description
FA Abandonment or withdrawal